Zydus ties up with Guardant Health

New Delhi: Zydus Lifesciences on Thursday said it has joined hands with oncology firm Guardant Health to jointly promote a portfolio of liquid and tissue biopsy tests across India and Nepal. The companies have inked a co-marketing agreement to jointly promote the Guardant360 portfolio in India and Nepal. The tests to be promoted include the Guardant360 and Guardant360 TissueNext tests for comprehensive genomic profiling and the Guardant360 Response test for monitoring response to treatment, the drug maker said in a statement.